Agranulocytosis after Metamizole Sodium Use
Metamizole sodium (Novalgine) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world and our country; however, it is banned in developed countries because of severe side effects. Here we present a case of a three-years- four- months-old girl who developed lif...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cukurova University
2015-09-01
|
Series: | Çukurova Üniversitesi Tıp Fakültesi Dergisi |
Subjects: | |
Online Access: | http://www.scopemed.org/fulltextpdf.php?mno=166170 |
Summary: | Metamizole sodium (Novalgine) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world and our country; however, it is banned in developed countries because of severe side effects. Here we present a case of a three-years- four- months-old girl who developed life-threatening agranulocytosis in his bone marrow after metamizole sodium use for fever, which resolved with granulocyte colony-stimulating factor therapy. [Cukurova Med J 2015; 40(3.000): 580-583] |
---|---|
ISSN: | 0250-5150 |